08093206 is referenced by 2 patents and cites 164 patents.

Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The conjugates may be formed in vivo or ex vivo. The modified peptides are administered to treat humans with diabetes and other related diseases.

Title
Methods involving long lasting synthetic exendin-4 peptide conjugates
Application Number
11/304446
Publication Number
8093206 (B2)
Application Date
December 14, 2005
Publication Date
January 10, 2012
Inventor
Serge St Pierre
Ile Bezard
CA
Anouk Leblanc
Montreal
CA
Darren L Holmes
Anaheim
CA, US
Benoit L Archeveque
Dorval
CA
Dominique P Bridon
San Francisco
CA, US
Agent
Morrison & Foerster
Assignee
Conjuchem
CA, US
IPC
A61K 38/22
View Original Source